Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksANW.L Regulatory News (ANW)

  • There is currently no data for ANW

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison review on Aberdeen New Thai Inv Trust (ANW)

1 Feb 2021 08:00

RNS Number : 3704N
Aberdeen New Thai Inv Trust PLC
29 January 2021
 

 

London, UK, 1 February 2021

 

 Edison issues review on Aberdeen New Thai Investment Trust (ANW)

Aberdeen New Thai Investment Trust (ANW) is the only London-listed investment trust focused on investing in Thailand and the manager Aberdeen Standard Investments (ASI) believes the Thai equity market remains inefficient. During 2020, the ANW team rebalanced the portfolio. ANW was not well positioned for the unforeseen pandemic and subsequent market rout, and performance disappointed. Nevertheless, the manager picked up undervalued stocks during the 2020 sell-off. The manager expects quality companies within the rebalanced portfolio that are market leaders to better weather the impacts of the pandemic and generate sustainable long-term returns.

 

ANW trades on a 15.4% discount to its cum-income NAV, wider than its three-year average of 14.0%, and a significant recovery from the March 2020 low (21.7%). Its double-digit gearing amplified the portfolio's underperformance in 2020, but means ANW should see improving performance as the country recovers and investors refocus on Thailand's brighter longer-term prospects within Asia.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Victoria Chernykh, +44 (0)20 3681 2522, investmenttrusts@edisongroup.com

Sarah Godfrey, +44 (0)20 3681 2519, investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLMMTMTJTBLB
Date   Source Headline
14th Aug 20205:11 pmRNSTransaction in Own Shares
14th Aug 202011:56 amRNSPortfolio disclosures
14th Aug 202011:35 amRNSNet Asset Value(s)
13th Aug 202011:19 amRNSNet Asset Value(s)
12th Aug 202012:40 pmRNSNet Asset Value(s)
11th Aug 202012:06 pmRNSNet Asset Value(s)
10th Aug 202012:28 pmRNSGearing disclosure
10th Aug 202011:33 amRNSNet Asset Value(s)
7th Aug 20205:14 pmRNSTransaction in Own Shares
7th Aug 202012:17 pmRNSNet Asset Value(s)
6th Aug 20205:06 pmRNSTransaction in Own Shares
6th Aug 20202:36 pmRNSMonth End Net Asset Value(s)
6th Aug 202011:39 amRNSNet Asset Value(s)
5th Aug 20205:19 pmRNSTransaction in Own Shares
5th Aug 202012:39 pmRNSNet Asset Value(s)
4th Aug 20205:02 pmRNSTransaction in Own Shares
4th Aug 202011:39 amRNSNet Asset Value(s)
3rd Aug 20202:19 pmRNSGearing disclosure
3rd Aug 20207:00 amRNSBlock listing Interim Review
31st Jul 202012:31 pmRNSNet Asset Value(s)
30th Jul 202012:22 pmRNSDirector/PDMR Shareholding
30th Jul 202012:01 pmRNSNet Asset Value(s)
29th Jul 202011:41 amRNSNet Asset Value(s)
28th Jul 202011:25 amRNSNet Asset Value(s)
27th Jul 202012:26 pmRNSGearing disclosure
27th Jul 202011:47 amRNSNet Asset Value(s)
24th Jul 202011:54 amRNSNet Asset Value(s)
23rd Jul 202012:27 pmRNSNet Asset Value(s)
22nd Jul 202011:41 amRNSNet Asset Value(s)
21st Jul 202012:00 pmRNSNet Asset Value(s)
20th Jul 20202:50 pmRNSGearing Disclosure
20th Jul 202012:33 pmRNSNet Asset Value(s)
17th Jul 202012:03 pmRNSNet Asset Value(s)
16th Jul 202011:42 amRNSNet Asset Value(s)
15th Jul 202011:57 amRNSNet Asset Value(s)
14th Jul 20203:01 pmRNSPortfolio disclosures
14th Jul 202011:26 amRNSNet Asset Value(s)
13th Jul 20202:45 pmRNSGearing disclosure
13th Jul 202012:02 pmRNSNet Asset Value(s)
10th Jul 202012:00 pmRNSNet Asset Value(s)
9th Jul 202011:51 amRNSNet Asset Value(s)
8th Jul 202012:28 pmRNSNet Asset Value(s)
7th Jul 202011:49 amRNSNet Asset Value(s)
6th Jul 20202:59 pmRNSMonth End Net Asset Value(s)
6th Jul 202012:32 pmRNSGearing disclosure
6th Jul 202011:24 amRNSNet Asset Value(s)
3rd Jul 202012:07 pmRNSNet Asset Value(s)
2nd Jul 202011:37 amRNSNet Asset Value(s)
1st Jul 202010:31 amRNSTotal Voting Rights
30th Jun 202011:17 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.